Nicolas MONJOTIN
Chief Operating Officer at Urosphere- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
-
Anglais Full professional proficiency
-
Allemand Limited working proficiency
Topline Score
Bio
0
/5.0 / Based on 0 ratingsFilter reviews by:
Experience
-
Urosphere
-
France
-
Biotechnology Research
-
1 - 100 Employee
-
Chief Operating Officer
-
Jun 2022 - Present
-
-
-
Pierre Fabre Group
-
France
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Head of Non Clinical Strategy
-
Jan 2019 - Jul 2022
- Identification of the Non-Clinical Strategy for the Established and Consumer Health Care products (innovation and valorisation).- Scientific evaluation of new assets for inclusion in the development pipeline.- Identification of partners, setting up and management of collaborations. - Management of the dedicated budget- Scientific communications in international conferences
-
-
Head of Scientific Outsourcing
-
Apr 2016 - Jan 2019
- Identification and Implementation of the Pierre Fabre scientific outsourcing strategy.- Management of 15 Outsourcing Managers.- Identification of preferred partners and setting up collaborations. - Pharmacological expertise for all the Pierre Fabre Group areas (Dossier Evaluation, Experimental design, Project analysis….).
-
-
Pharmacology Laboratory manager / Study Director
-
Jan 2011 - Apr 2016
- Planning and management of innovating preclinical projects - Pharmacological characterization and development of drug candidates.- Research and selection of CROs, monitoring of outsourced studies. - Team management / Carrier management. - Scientific communications in international congress and publications.- Analysis and interpretation of the results.- Collaborations with internationals key opinion leaders.- Framework in transverse mode (GLP environment).
-
-
Pharmacological Scientist
-
2008 - 2011
- Development and carrying out preclinical in vivo and in vitro studies.- Audit and statistical analysis of the results.- Redaction of study reports.- Interaction with internal and external sponsors and contractors.- Regulatory environment
-
-
-
UROSPHERE
-
France
-
Biotechnology Research
-
1 - 100 Employee
-
Pharmacological Scientist
-
Jan 2006 - May 2008
- Development and carrying out preclinical in vivo and in vitro studies. - Audit and statistical analysis of the results. - Redaction of study reports. - Interaction with internal and external sponsors and contractors. - Regulatory environment. - Development and carrying out preclinical in vivo and in vitro studies. - Audit and statistical analysis of the results. - Redaction of study reports. - Interaction with internal and external sponsors and contractors. - Regulatory environment.
-
-
-
Organon
-
United States
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Pharmacological Scientist
-
Jan 2005 - Dec 2005
- Development and carrying out preclinical in vivo and in vitro studies. - Audit and statistical analysis of the results. - Redaction of study reports. - Interaction with internal and external sponsors and contractors. - Regulatory environment. - Development and carrying out preclinical in vivo and in vitro studies. - Audit and statistical analysis of the results. - Redaction of study reports. - Interaction with internal and external sponsors and contractors. - Regulatory environment.
-
-
Education
-
Ecole doctorale Biologie Sante Biotechnologies
doctorat de pharmacologie, Pharmacologie -
Cnam
Ingénieur en sciences et techniques du vivant, Biologie -
Université Blaise Pascal (Clermont-II) - Clermont-Ferrand
licence, biologie cellulaire et physiologie -
IUT Clermont ferrand
DUT génie biologique option ABB, Biology, General -
Ecole nationale vétérinaire de Toulouse
Utilisation et protection de l'animal de laboratoire niveau 1 (concepteur projet) -
saint alyre
Baccalauréat, SVT -
saint alyre